High Incidence of Peridiagnosis Thromboembolic Events In Patients with BRAF Mutant Lung Cancer

被引：0

作者：

Salcedo, I. Aparicio ^{[1
]}

Gomez, P. Iranzo ^{[2
]}

Reyes, R. ^{[3
]}

de Cabo, H. Bote ^{[4
]}

Morgui, M. Saigi ^{[5
]}

Beranek, M. Bringas ^{[1
]}

Bosch-Barrera, J. ^{[6
]}

Jaime, J. Corral ^{[7
]}

Aparisi, F. Aparisi ^{[8
]}

Rodriguez, J. C. Ruffinelli ^{[9
]}

Munarriz, B. Jimenez ^{[10
]}

Alfranca, Y. Lage ^{[11
]}

Lopez-Castro, R. ^{[12
]}

Tarruella, M. Majem ^{[13
]}

Estevez, S. Vazquez ^{[14
]}

Cortes, A. Artal ^{[15
]}

Rodriguez-Perez, A. R. ^{[16
]}

Quintela, M. Lazaro ^{[17
]}

Torres, J. M. Sanchez ^{[18
]}

Aransay, N. Reguart ^{[19
]}

Salamero, M. Cucurull ^{[20
]}

Gil-Bazo, I. ^{[7
]}

Herrero, C. Camps ^{[8
]}

Alforja, E. Nadal ^{[9
]}

Aldagalan, A. del Barrio Diaz ^{[10
]}

Lopez, P. Garrido ^{[11
]}

Gomez, M. Domine ^{[21
]}

Alvarez, R. Alvarez ^{[1
]}

Martin, A. J. Munoz ^{[1
]}

Blanco, A. Calles ^{[1
]}

机构：

[1] Univ Gregorio Maranon, Hosp Gen, Madrid, Spain

[2] Hosp Univ Vall dHebron, Barcelona, Spain

[3] Hosp Clin Barcelona, Barcelona, Spain

[4] Hosp Univ 12 Octubre, Madrid, Spain

[5] Hosp Germans Trias Pujol, Inst Catala dOncologia ICO, Badalona, Spain

[6] Hosp Univ Girona, Inst Catala Oncol, Girona, Spain

[7] Univ Navarra, Pamplona, Spain

[8] Univ Valencia, Consorci Hosp Gen, Valencia, Spain

[9] Univ Bellvitge, Inst Catala Oncol ICO, Hospitalet Llobregat, Ctr Sanitari, Barcelona, Spain

[10] Hosp HM Univ Sanchinarro CIOCC, Madrid, Spain

[11] Hosp HM Univ Sanchinarro CIOCC, Madrid, Spain

[12] Ramon & Cajal Univ Hosp, Madrid, Spain

[13] Univ Valladolid, Hosp Clinico, Valladolid, Spain

[14] Hosp Univ Lucus Augusti, Lugo, Spain

[15] Hosp Univ Miguel Servet, Zaragoza, Spain

[16] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[17] Hosp Univ Alvaro Cunqueiro, Vigo, Spain

[18] Princesa Univ Hosp, Madrid, Spain

[19] Hosp Clin Barcelona ICMHO, Barcelona, Spain

[20] Hosp Germans Trias Pujol, Inst Catala Oncol ICO, Badalona, Spain

[21] Hosp Univ Fdn Jimenez Diaz, IIS FJD, Madrid, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期

关键词：

BRAF Mutant Lung Cancer; Thrombosis; Targeted Therapy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP08.02-07

引用

页码：S433 / S434

页数：2

共 50 条

[41] Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival
Jacobson, Geraldine
Lammli, John
Zarnba, Gideon
Hua, Lei
Goodheart, Michael J.
GYNECOLOGIC ONCOLOGY, 2009, 113 (02) : 240 - 244
[42] Incidence and outcomes of thromboembolic events in plastic surgery infirmary patients
Alvarenga, Mendes
Almeida, Alexandre
Horta, Ricardo
CIRUGIA Y CIRUJANOS, 2022, 90 (05): : 617 - 622
[43] THROMBOEMBOLIC EVENTS IN FRENCH BREAST AND PROSTATE CANCER PATIENTS HOSPITALIZED IN 2011 AND 2012: INCIDENCE AND COSTS
Scotte, F.
Vainchtock, A.
Borget, I.
Martelli, N.
ANNALS OF ONCOLOGY, 2014, 25
[44] Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy EDITORIAL COMMENT
Greco, Patricia S.
Bazzi, Ali A.
McLean, Karen
Reynolds, R. Kevin
Spencer, Ryan J.
Johnston, Carolyn M.
Liu, J. Rebecca
Uppal, Shitanshu
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (09) : 537 - 538
[45] Incidence of thromboembolic events in a prospective nationwide registry of cancer patients initiating systemic chemotherapy.
Khorana, AA
Culakova, E
Lyman, GH
Francis, CW
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 733S - 733S
[46] Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience
L. Gutierrez-Sainz
V. Martinez-Marin
D. Viñal
D. Martinez-Perez
J. Pedregosa
J. A. Garcia-Cuesta
J. Villamayor
P. Zamora
A. Pinto
A. Redondo
B. Castelo
P. Cruz
O. Higuera
A. Custodio
A. Gallego
D. Sanchez-Cabrero
J. de Castro-Carpeño
E. Espinosa
J. Feliu
Clinical and Translational Oncology, 2021, 23 : 1245 - 1252
[47] Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience
Gutierrez-Sainz, L.
Martinez-Marin, V.
Vinal, D.
Martinez-Perez, D.
Pedregosa, J.
Garcia-Cuesta, J. A.
Villamayor, J.
Zamora, P.
Pinto, A.
Redondo, A.
Castelo, B.
Cruz, P.
Higuera, O.
Custodio, A.
Gallego, A.
Sanchez-Cabrero, D.
de Castro-Carpeno, J.
Espinosa, E.
Feliu, J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (06): : 1245 - 1252
[48] Clinical Characteristics and Outcomes of Patients with EGFR-mutant Lung Cancer with Acquired BRAF Alterations
Sui, J.
Yang, S. R.
Bowman, A. S.
Vankayala, P.
Falcon, C.
Somwar, R.
Drilon, A. E.
Riely, G. J.
Kris, M. G.
Ladanyi, M.
Yu, H. A.
Offin, M.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S337 - S337
[49] BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Falchook, Gerald S.
Millward, Michael
Hong, David
Naing, Aung
Piha-Paul, Sarina
Waguespack, Steven G.
Cabanillas, Maria E.
Sherman, Steven I.
Ma, Bo
Curtis, Martin
Goodman, Vicki
Kurzrock, Razelle
THYROID, 2015, 25 (01) : 71 - 77
[50] Incidence, Risk Factors, and Outcomes Among Patients with Venous Thromboembolic Events After Lung Transplantation in the Lung Allocation Score Era
Kanade, R.
Smith, L.
Mahan, L.
Bollineni, S.
Mullins, J.
Kaza, V.
Mohanka, M.
Wait, M.
Torres, F.
Banga, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197

← 1 2 3 4 5 →